Tsai L, Peng M, Chang C, Wen L, Liu L, Liang X, et al. ZSCAN4 interacts with PARP1 to promote DNA repair in mouse embryonic stem cells. Cell Biosci. 2023;13:193 pubmed publisher

Oh S, Lim J, Son M, Ahn J, Song K, Lee H, et al. TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway. Nat Commun. 2023;14:2691 pubmed publisher

Díaz Tejeda Y, Guido Jimenez M, López Carbajal H, Amador Molina A, Méndez Martínez R, Gariglio Vidal P, et al. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18. Viruses. 2021;13: pubmed publisher

Chen K, Oztürk K, Liefeld T, Reich M, Mesirov J, Carter H, et al. A phenotypically supervised single-cell analysis protocol to study within-cell-type heterogeneity of cultured mammalian cells. STAR Protoc. 2021;2:100561 pubmed publisher

Chang W, Peng M, Hsu J, Xu J, Cho H, Hsieh Li H, et al. Effects of Survival Motor Neuron Protein on Germ Cell Development in Mouse and Human. Int J Mol Sci. 2021;22: pubmed publisher

Ruiz G, Valencia González H, Perez Montiel D, Muñoz F, Ocadiz Delgado R, Fernandez Retana J, et al. Genes Involved in the Transcriptional Regulation of Pluripotency Are Expressed in Malignant Tumors of the Uterine Cervix and Can Induce Tumorigenic Capacity in a Nontumorigenic Cell Line. Stem Cells Int. 2019;2019:7683817 pubmed publisher

Uhlmann C, Kuhn L, Tigges J, Fritsche E, Kahlert U. Efficient Modulation of TP53 Expression in Human Induced Pluripotent Stem Cells. Curr Protoc Stem Cell Biol. 2020;52:e102 pubmed publisher

García Olloqui P, Rodríguez Madoz J, Di Scala M, Abizanda G, Vales A, Olague C, et al. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors. J Tissue Eng Regen Med. 2020;14:123-134 pubmed publisher

Wang R, Pscheid R, Ghumra A, Kan L, Cochrane S, Fairclough L, et al. Towards a surrogate system to express human lipid binding TCRs. Biotechnol Lett. 2019;41:1095-1104 pubmed publisher

Wang X, Sun D, Tai J, Chen S, Yu M, Ren D, et al. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway. J Exp Clin Cancer Res. 2018;37:27 pubmed publisher

Lim S, Macheleidt I, Dalvi P, Schäfer S, Kerick M, Ozretić L, et al. LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells. Sci Rep. 2017;7:10292 pubmed publisher

Talbot N, Sparks W, Phillips C, Ealy A, Powell A, Caperna T, et al. Bovine trophectoderm cells induced from bovine fibroblasts with induced pluripotent stem cell reprogramming factors. Mol Reprod Dev. 2017;84:468-485 pubmed publisher

Shah M, Cardenas R, Wang B, Persson J, Mongan N, Grabowska A, et al. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells. Mol Cancer. 2017;16:38 pubmed publisher

Zhang X, Ren D, Guo L, Wang L, Wu S, Lin C, et al. Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer. Breast Cancer Res. 2017;19:15 pubmed publisher

Tsanov K, Pearson D, Wu Z, Han A, Triboulet R, Seligson M, et al. LIN28 phosphorylation by MAPK/ERK couples signalling to the post-transcriptional control of pluripotency. Nat Cell Biol. 2017;19:60-67 pubmed publisher

Zeng S, Liu L, Ouyang Q, Zhao Y, Lin G, Hu L, et al. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene. Stem Cell Res. 2016;17:208-211 pubmed publisher

Chang W, Hwu Y, Xu J, Lin C, Wang S, Cheng A, et al. Derivation of Patient Specific Pluripotent Stem Cells Using Clinically Discarded Cumulus Cells. PLoS ONE. 2016;11:e0165715 pubmed publisher

Hanna J, Garcia M, Go J, Finkelstein D, Kodali K, Pagala V, et al. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma. Cell Death Dis. 2016;7:e2256 pubmed publisher

Tenga A, Beard J, Takwi A, Wang Y, Chen T. Regulation of Nuclear Receptor Nur77 by miR-124. PLoS ONE. 2016;11:e0148433 pubmed publisher

Palla A, Piazzolla D, Alcazar N, Cañamero M, Graña O, Gómez López G, et al. The pluripotency factor NANOG promotes the formation of squamous cell carcinomas. Sci Rep. 2015;5:10205 pubmed publisher

Gayle S, Pan Y, Landrette S, Xu T. piggyBac insertional mutagenesis screen identifies a role for nuclear RHOA in human ES cell differentiation. Stem Cell Reports. 2015;4:926-38 pubmed publisher

Leng L, Tan Y, Gong F, Hu L, Ouyang Q, Zhao Y, et al. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency. Hum Reprod. 2015;30:737-48 pubmed publisher

Langlois T, da Costa Reis Monte Mor B, Lenglet G, Droin N, Marty C, Le Couedic J, et al. TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells. Stem Cells. 2014;32:2084-97 pubmed publisher

Liao W, Liaw C, Huang Y, Han H, Hsu H, Hwang S, et al. Cyclohexylmethyl Flavonoids Suppress Propagation of Breast Cancer Stem Cells via Downregulation of NANOG. Evid Based Complement Alternat Med. 2013;2013:170261 pubmed publisher

Wang X, Wang J, Huang V, Place R, Li L. Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J. 2012;443:821-8 pubmed publisher

Dick E, Matsa E, Young L, Darling D, Denning C. Faster generation of hiPSCs by coupling high-titer lentivirus and column-based positive selection. Nat Protoc. 2011;6:701-14 pubmed publisher

Yu J, Vodyanik M, Smuga Otto K, Antosiewicz Bourget J, Frane J, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917-20 pubmed